Knight Therapeutics Inc. (KHTRF) Q1 2025 Earnings Call Transcript

Knight Therapeutics Inc. (OTCPK:KHTRF) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET

Company Participants

Samira Sakhia – President and Chief Executive Officer
Arvind Utchanah – Chief Financial Officer

Conference Call Participants

Michael Freeman – Raymond James

Operator

Good morning, ladies and gentlemen. My name is Elle [ph], and I will be your operator today. Welcome to Knight Therapeutics First Quarter 2025 Results Conference Call. Before turning the call over to Samira Sakhia, President and CEO of Knight, listeners are reminded that portions of today's discussion may, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements.

The company considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but cautions that these assumptions regarding the future events, many of which are beyond the control of the company and its subsidiaries, may ultimately prove to be incorrect. The company disclaims any intention or obligation to update or revise any forward-looking statements, whether a result of new information, future events, except as required by law.

We would also like to remind you questions during today's call will be taken from analysts only. Should there be any further questions, please contact Knight's Investor Relations department via e-mail to [e-mail] or via phone at [phone].

I would like to remind everyone that this call is being recorded today, May 8, 2025, and would now like to turn the meeting over to your host for today's call, Samira Sakhia. Please go ahead, Ms. Sakhia.

Samira Sakhia

Thank you, Elle. Good morning, everyone, and welcome to Knight Therapeutics first quarter 2025 conference call.

I'm joined on today's call with Amal Khouri, our Chief Business Officer; and Arvind Utchanah, our Chief Financial Officer.